SHENZHEN, China, March 3 /PRNewswire/ -- Shenzhen Beike Biotechnology Co., Ltd. has announced the successful treatment with umbilical cord stem cells of the youngest stroke patient ever to undergo such a procedure. The announcement was made following a two-month evaluation period by physicians in her native country, Hungary, to verify the positive results. Starting from October 28th, Beike provided umbilical cord stem cells to the Nanshan People's Hospital for the treatment of a four-month-old Hungarian baby girl named Timea Gresco, who had suffered a stroke when she was delivered three months prematurely. Umbilical cord stem cells were delivered intravenously over...